CELL PROLIFERATION-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2203621, encodeId=60a722036217f, content=旧的系统显示了Under review，是送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小王, createdTime=Thu May 09 10:29:11 CST 2024, time=2024-05-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2118154, encodeId=430721181541e, content=2月15号投稿，现在3月7号，还在awaiting reviewer assignment，发邮件没回应，托人问了华西的副主编，说帮忙看下，3天了也没动静，正在考虑转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61698567057, createdName=ms5000001252099123, createdTime=Tue Mar 07 17:36:16 CST 2023, time=2023-03-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2145106, encodeId=955021451062a, content=偏重的研究方向：肿瘤基础研究;干细胞;肿瘤生物学 经验分享：外审5个月，4个小修，编辑拒稿。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5a28115392, createdName=ms3000000199710851, createdTime=Tue Jun 27 22:54:13 CST 2023, time=2023-06-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2097725, encodeId=4d75209e7251f, content=偏重的研究方向：细胞增殖 经验分享：分值高的二区杂志，6个审稿人给了一些不痛不痒的小意见，没有拒稿，但是被编辑给拒了，垃圾。转投了其他一区杂志，接受了，因祸得福, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb028255336, createdName=ms6000000988225388, createdTime=Tue Nov 01 03:34:30 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237083, encodeId=4a0b123e083bd, content=2.25 投稿，不知为何，5月才开始外审， 6.3通知Major revision，6.20修回，7.14通知Minor revision，7.26 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=COCO-么么哒, createdTime=Sun Aug 07 13:58:40 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158571, encodeId=e37e21585e140, content=偏重的研究方向：发育 经验分享：投稿的友友们， 我是9.17 投稿 9.18 分配编辑 9.19 Under review 我想问一下Under review 不属于外审，是期刊内部评审，意思是主编那关已经过了吗？送外审的可能性大嘛有知道的友友可以麻烦回复告知指点一下嘛~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77c6565435, createdName=ms8000000172957012, createdTime=Tue Sep 19 20:55:28 CST 2023, time=2023-09-19, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2201363, encodeId=ae672201363d5, content=请问一下，这个期刊什么时候送外审？会有状态变化或者邮件告知吗？投稿已经两周了，一直是Under Review状态，旁边显示“This submission is under consideration and cannot be edited. Further information will be emailed to you by the journal editorial office.”, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8332469177, createdName=12433741m11(暂无昵称), createdTime=Wed May 01 11:16:29 CST 2024, time=2024-05-01, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2204994, encodeId=1c162204994e2, content=请问是小CDD口碑好，还是CELL PROLIFERATION口碑好哇？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8332469177, createdName=12433741m11(暂无昵称), createdTime=Thu May 16 11:05:39 CST 2024, time=2024-05-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2153391, encodeId=54492153391da, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：第二次显示awaiting editor decision一周多了……第一次的时候三天又变成等待评分……这次一周也没变化了……有知道的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200608/69dd05c9fcfa4768838a5589b5b25dd6/e3def69d3a5a45e8b6b33e44bf34132b.jpg, createdBy=8b9295286, createdName=刘洋1981, createdTime=Fri Aug 18 11:32:32 CST 2023, time=2023-08-18, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=977961, encodeId=49329e7961a0, content=偏重的研究方向：增殖;肿瘤 经验分享：投稿后拒稿快吗？不会等了一个月又被拒吧😭伤不起了我<a href='/topic/show?id=2daf446643' target=_blank style='color:#2F92EE;'>#cell proliferation#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=4466, encryptionId=2daf446643, topicName=cell proliferation)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/9883684c50eb4525aa0007900c15ab09/c44d99673a04497daa77b8386586df68.jpg, createdBy=70f62430863, createdName=lovebanana, createdTime=Tue Jun 29 16:44:46 CST 2021, time=2021-06-29, status=1, ipAttribution=)]

2024-05-09 庸医小王来自湖北省

旧的系统显示了Under review，是送外审了吗？

9 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2203621, encodeId=60a722036217f, content=旧的系统显示了Under review，是送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小王, createdTime=Thu May 09 10:29:11 CST 2024, time=2024-05-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2118154, encodeId=430721181541e, content=2月15号投稿，现在3月7号，还在awaiting reviewer assignment，发邮件没回应，托人问了华西的副主编，说帮忙看下，3天了也没动静，正在考虑转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61698567057, createdName=ms5000001252099123, createdTime=Tue Mar 07 17:36:16 CST 2023, time=2023-03-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2145106, encodeId=955021451062a, content=偏重的研究方向：肿瘤基础研究;干细胞;肿瘤生物学 经验分享：外审5个月，4个小修，编辑拒稿。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5a28115392, createdName=ms3000000199710851, createdTime=Tue Jun 27 22:54:13 CST 2023, time=2023-06-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2097725, encodeId=4d75209e7251f, content=偏重的研究方向：细胞增殖 经验分享：分值高的二区杂志，6个审稿人给了一些不痛不痒的小意见，没有拒稿，但是被编辑给拒了，垃圾。转投了其他一区杂志，接受了，因祸得福, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb028255336, createdName=ms6000000988225388, createdTime=Tue Nov 01 03:34:30 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237083, encodeId=4a0b123e083bd, content=2.25 投稿，不知为何，5月才开始外审， 6.3通知Major revision，6.20修回，7.14通知Minor revision，7.26 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=COCO-么么哒, createdTime=Sun Aug 07 13:58:40 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158571, encodeId=e37e21585e140, content=偏重的研究方向：发育 经验分享：投稿的友友们， 我是9.17 投稿 9.18 分配编辑 9.19 Under review 我想问一下Under review 不属于外审，是期刊内部评审，意思是主编那关已经过了吗？送外审的可能性大嘛有知道的友友可以麻烦回复告知指点一下嘛~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77c6565435, createdName=ms8000000172957012, createdTime=Tue Sep 19 20:55:28 CST 2023, time=2023-09-19, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2201363, encodeId=ae672201363d5, content=请问一下，这个期刊什么时候送外审？会有状态变化或者邮件告知吗？投稿已经两周了，一直是Under Review状态，旁边显示“This submission is under consideration and cannot be edited. Further information will be emailed to you by the journal editorial office.”, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8332469177, createdName=12433741m11(暂无昵称), createdTime=Wed May 01 11:16:29 CST 2024, time=2024-05-01, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2204994, encodeId=1c162204994e2, content=请问是小CDD口碑好，还是CELL PROLIFERATION口碑好哇？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8332469177, createdName=12433741m11(暂无昵称), createdTime=Thu May 16 11:05:39 CST 2024, time=2024-05-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2153391, encodeId=54492153391da, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：第二次显示awaiting editor decision一周多了……第一次的时候三天又变成等待评分……这次一周也没变化了……有知道的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200608/69dd05c9fcfa4768838a5589b5b25dd6/e3def69d3a5a45e8b6b33e44bf34132b.jpg, createdBy=8b9295286, createdName=刘洋1981, createdTime=Fri Aug 18 11:32:32 CST 2023, time=2023-08-18, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=977961, encodeId=49329e7961a0, content=偏重的研究方向：增殖;肿瘤 经验分享：投稿后拒稿快吗？不会等了一个月又被拒吧😭伤不起了我<a href='/topic/show?id=2daf446643' target=_blank style='color:#2F92EE;'>#cell proliferation#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=4466, encryptionId=2daf446643, topicName=cell proliferation)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/9883684c50eb4525aa0007900c15ab09/c44d99673a04497daa77b8386586df68.jpg, createdBy=70f62430863, createdName=lovebanana, createdTime=Tue Jun 29 16:44:46 CST 2021, time=2021-06-29, status=1, ipAttribution=)]

2023-03-07 ms5000001252099123 来自浙江省

2月15号投稿，现在3月7号，还在awaiting reviewer assignment，发邮件没回应，托人问了华西的副主编，说帮忙看下，3天了也没动静，正在考虑转投

48 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2203621, encodeId=60a722036217f, content=旧的系统显示了Under review，是送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小王, createdTime=Thu May 09 10:29:11 CST 2024, time=2024-05-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2118154, encodeId=430721181541e, content=2月15号投稿，现在3月7号，还在awaiting reviewer assignment，发邮件没回应，托人问了华西的副主编，说帮忙看下，3天了也没动静，正在考虑转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61698567057, createdName=ms5000001252099123, createdTime=Tue Mar 07 17:36:16 CST 2023, time=2023-03-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2145106, encodeId=955021451062a, content=偏重的研究方向：肿瘤基础研究;干细胞;肿瘤生物学 经验分享：外审5个月，4个小修，编辑拒稿。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5a28115392, createdName=ms3000000199710851, createdTime=Tue Jun 27 22:54:13 CST 2023, time=2023-06-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2097725, encodeId=4d75209e7251f, content=偏重的研究方向：细胞增殖 经验分享：分值高的二区杂志，6个审稿人给了一些不痛不痒的小意见，没有拒稿，但是被编辑给拒了，垃圾。转投了其他一区杂志，接受了，因祸得福, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb028255336, createdName=ms6000000988225388, createdTime=Tue Nov 01 03:34:30 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237083, encodeId=4a0b123e083bd, content=2.25 投稿，不知为何，5月才开始外审， 6.3通知Major revision，6.20修回，7.14通知Minor revision，7.26 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=COCO-么么哒, createdTime=Sun Aug 07 13:58:40 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158571, encodeId=e37e21585e140, content=偏重的研究方向：发育 经验分享：投稿的友友们， 我是9.17 投稿 9.18 分配编辑 9.19 Under review 我想问一下Under review 不属于外审，是期刊内部评审，意思是主编那关已经过了吗？送外审的可能性大嘛有知道的友友可以麻烦回复告知指点一下嘛~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77c6565435, createdName=ms8000000172957012, createdTime=Tue Sep 19 20:55:28 CST 2023, time=2023-09-19, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2201363, encodeId=ae672201363d5, content=请问一下，这个期刊什么时候送外审？会有状态变化或者邮件告知吗？投稿已经两周了，一直是Under Review状态，旁边显示“This submission is under consideration and cannot be edited. Further information will be emailed to you by the journal editorial office.”, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8332469177, createdName=12433741m11(暂无昵称), createdTime=Wed May 01 11:16:29 CST 2024, time=2024-05-01, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2204994, encodeId=1c162204994e2, content=请问是小CDD口碑好，还是CELL PROLIFERATION口碑好哇？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8332469177, createdName=12433741m11(暂无昵称), createdTime=Thu May 16 11:05:39 CST 2024, time=2024-05-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2153391, encodeId=54492153391da, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：第二次显示awaiting editor decision一周多了……第一次的时候三天又变成等待评分……这次一周也没变化了……有知道的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200608/69dd05c9fcfa4768838a5589b5b25dd6/e3def69d3a5a45e8b6b33e44bf34132b.jpg, createdBy=8b9295286, createdName=刘洋1981, createdTime=Fri Aug 18 11:32:32 CST 2023, time=2023-08-18, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=977961, encodeId=49329e7961a0, content=偏重的研究方向：增殖;肿瘤 经验分享：投稿后拒稿快吗？不会等了一个月又被拒吧😭伤不起了我<a href='/topic/show?id=2daf446643' target=_blank style='color:#2F92EE;'>#cell proliferation#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=4466, encryptionId=2daf446643, topicName=cell proliferation)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/9883684c50eb4525aa0007900c15ab09/c44d99673a04497daa77b8386586df68.jpg, createdBy=70f62430863, createdName=lovebanana, createdTime=Tue Jun 29 16:44:46 CST 2021, time=2021-06-29, status=1, ipAttribution=)]

2023-06-27 ms3000000199710851 来自浙江省

偏重的研究方向：肿瘤基础研究;干细胞;肿瘤生物学
经验分享：外审5个月，4个小修，编辑拒稿。。。

40 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2203621, encodeId=60a722036217f, content=旧的系统显示了Under review，是送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小王, createdTime=Thu May 09 10:29:11 CST 2024, time=2024-05-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2118154, encodeId=430721181541e, content=2月15号投稿，现在3月7号，还在awaiting reviewer assignment，发邮件没回应，托人问了华西的副主编，说帮忙看下，3天了也没动静，正在考虑转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61698567057, createdName=ms5000001252099123, createdTime=Tue Mar 07 17:36:16 CST 2023, time=2023-03-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2145106, encodeId=955021451062a, content=偏重的研究方向：肿瘤基础研究;干细胞;肿瘤生物学 经验分享：外审5个月，4个小修，编辑拒稿。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5a28115392, createdName=ms3000000199710851, createdTime=Tue Jun 27 22:54:13 CST 2023, time=2023-06-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2097725, encodeId=4d75209e7251f, content=偏重的研究方向：细胞增殖 经验分享：分值高的二区杂志，6个审稿人给了一些不痛不痒的小意见，没有拒稿，但是被编辑给拒了，垃圾。转投了其他一区杂志，接受了，因祸得福, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb028255336, createdName=ms6000000988225388, createdTime=Tue Nov 01 03:34:30 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237083, encodeId=4a0b123e083bd, content=2.25 投稿，不知为何，5月才开始外审， 6.3通知Major revision，6.20修回，7.14通知Minor revision，7.26 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=COCO-么么哒, createdTime=Sun Aug 07 13:58:40 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158571, encodeId=e37e21585e140, content=偏重的研究方向：发育 经验分享：投稿的友友们， 我是9.17 投稿 9.18 分配编辑 9.19 Under review 我想问一下Under review 不属于外审，是期刊内部评审，意思是主编那关已经过了吗？送外审的可能性大嘛有知道的友友可以麻烦回复告知指点一下嘛~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77c6565435, createdName=ms8000000172957012, createdTime=Tue Sep 19 20:55:28 CST 2023, time=2023-09-19, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2201363, encodeId=ae672201363d5, content=请问一下，这个期刊什么时候送外审？会有状态变化或者邮件告知吗？投稿已经两周了，一直是Under Review状态，旁边显示“This submission is under consideration and cannot be edited. Further information will be emailed to you by the journal editorial office.”, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8332469177, createdName=12433741m11(暂无昵称), createdTime=Wed May 01 11:16:29 CST 2024, time=2024-05-01, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2204994, encodeId=1c162204994e2, content=请问是小CDD口碑好，还是CELL PROLIFERATION口碑好哇？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8332469177, createdName=12433741m11(暂无昵称), createdTime=Thu May 16 11:05:39 CST 2024, time=2024-05-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2153391, encodeId=54492153391da, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：第二次显示awaiting editor decision一周多了……第一次的时候三天又变成等待评分……这次一周也没变化了……有知道的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200608/69dd05c9fcfa4768838a5589b5b25dd6/e3def69d3a5a45e8b6b33e44bf34132b.jpg, createdBy=8b9295286, createdName=刘洋1981, createdTime=Fri Aug 18 11:32:32 CST 2023, time=2023-08-18, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=977961, encodeId=49329e7961a0, content=偏重的研究方向：增殖;肿瘤 经验分享：投稿后拒稿快吗？不会等了一个月又被拒吧😭伤不起了我<a href='/topic/show?id=2daf446643' target=_blank style='color:#2F92EE;'>#cell proliferation#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=4466, encryptionId=2daf446643, topicName=cell proliferation)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/9883684c50eb4525aa0007900c15ab09/c44d99673a04497daa77b8386586df68.jpg, createdBy=70f62430863, createdName=lovebanana, createdTime=Tue Jun 29 16:44:46 CST 2021, time=2021-06-29, status=1, ipAttribution=)]

2022-11-01 ms6000000988225388

偏重的研究方向：细胞增殖
经验分享：分值高的二区杂志，6个审稿人给了一些不痛不痒的小意见，没有拒稿，但是被编辑给拒了，垃圾。转投了其他一区杂志，接受了，因祸得福

66 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2203621, encodeId=60a722036217f, content=旧的系统显示了Under review，是送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小王, createdTime=Thu May 09 10:29:11 CST 2024, time=2024-05-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2118154, encodeId=430721181541e, content=2月15号投稿，现在3月7号，还在awaiting reviewer assignment，发邮件没回应，托人问了华西的副主编，说帮忙看下，3天了也没动静，正在考虑转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61698567057, createdName=ms5000001252099123, createdTime=Tue Mar 07 17:36:16 CST 2023, time=2023-03-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2145106, encodeId=955021451062a, content=偏重的研究方向：肿瘤基础研究;干细胞;肿瘤生物学 经验分享：外审5个月，4个小修，编辑拒稿。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5a28115392, createdName=ms3000000199710851, createdTime=Tue Jun 27 22:54:13 CST 2023, time=2023-06-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2097725, encodeId=4d75209e7251f, content=偏重的研究方向：细胞增殖 经验分享：分值高的二区杂志，6个审稿人给了一些不痛不痒的小意见，没有拒稿，但是被编辑给拒了，垃圾。转投了其他一区杂志，接受了，因祸得福, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb028255336, createdName=ms6000000988225388, createdTime=Tue Nov 01 03:34:30 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237083, encodeId=4a0b123e083bd, content=2.25 投稿，不知为何，5月才开始外审， 6.3通知Major revision，6.20修回，7.14通知Minor revision，7.26 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=COCO-么么哒, createdTime=Sun Aug 07 13:58:40 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158571, encodeId=e37e21585e140, content=偏重的研究方向：发育 经验分享：投稿的友友们， 我是9.17 投稿 9.18 分配编辑 9.19 Under review 我想问一下Under review 不属于外审，是期刊内部评审，意思是主编那关已经过了吗？送外审的可能性大嘛有知道的友友可以麻烦回复告知指点一下嘛~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77c6565435, createdName=ms8000000172957012, createdTime=Tue Sep 19 20:55:28 CST 2023, time=2023-09-19, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2201363, encodeId=ae672201363d5, content=请问一下，这个期刊什么时候送外审？会有状态变化或者邮件告知吗？投稿已经两周了，一直是Under Review状态，旁边显示“This submission is under consideration and cannot be edited. Further information will be emailed to you by the journal editorial office.”, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8332469177, createdName=12433741m11(暂无昵称), createdTime=Wed May 01 11:16:29 CST 2024, time=2024-05-01, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2204994, encodeId=1c162204994e2, content=请问是小CDD口碑好，还是CELL PROLIFERATION口碑好哇？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8332469177, createdName=12433741m11(暂无昵称), createdTime=Thu May 16 11:05:39 CST 2024, time=2024-05-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2153391, encodeId=54492153391da, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：第二次显示awaiting editor decision一周多了……第一次的时候三天又变成等待评分……这次一周也没变化了……有知道的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200608/69dd05c9fcfa4768838a5589b5b25dd6/e3def69d3a5a45e8b6b33e44bf34132b.jpg, createdBy=8b9295286, createdName=刘洋1981, createdTime=Fri Aug 18 11:32:32 CST 2023, time=2023-08-18, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=977961, encodeId=49329e7961a0, content=偏重的研究方向：增殖;肿瘤 经验分享：投稿后拒稿快吗？不会等了一个月又被拒吧😭伤不起了我<a href='/topic/show?id=2daf446643' target=_blank style='color:#2F92EE;'>#cell proliferation#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=4466, encryptionId=2daf446643, topicName=cell proliferation)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/9883684c50eb4525aa0007900c15ab09/c44d99673a04497daa77b8386586df68.jpg, createdBy=70f62430863, createdName=lovebanana, createdTime=Tue Jun 29 16:44:46 CST 2021, time=2021-06-29, status=1, ipAttribution=)]

2022-08-07 COCO-么么哒

2.25 投稿，不知为何，5月才开始外审， 6.3通知Major revision，6.20修回，7.14通知Minor revision，7.26 Accept

70 14

展开14条回复

[GetPortalCommentsPageByObjectIdResponse(id=2203621, encodeId=60a722036217f, content=旧的系统显示了Under review，是送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小王, createdTime=Thu May 09 10:29:11 CST 2024, time=2024-05-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2118154, encodeId=430721181541e, content=2月15号投稿，现在3月7号，还在awaiting reviewer assignment，发邮件没回应，托人问了华西的副主编，说帮忙看下，3天了也没动静，正在考虑转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61698567057, createdName=ms5000001252099123, createdTime=Tue Mar 07 17:36:16 CST 2023, time=2023-03-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2145106, encodeId=955021451062a, content=偏重的研究方向：肿瘤基础研究;干细胞;肿瘤生物学 经验分享：外审5个月，4个小修，编辑拒稿。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5a28115392, createdName=ms3000000199710851, createdTime=Tue Jun 27 22:54:13 CST 2023, time=2023-06-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2097725, encodeId=4d75209e7251f, content=偏重的研究方向：细胞增殖 经验分享：分值高的二区杂志，6个审稿人给了一些不痛不痒的小意见，没有拒稿，但是被编辑给拒了，垃圾。转投了其他一区杂志，接受了，因祸得福, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb028255336, createdName=ms6000000988225388, createdTime=Tue Nov 01 03:34:30 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237083, encodeId=4a0b123e083bd, content=2.25 投稿，不知为何，5月才开始外审， 6.3通知Major revision，6.20修回，7.14通知Minor revision，7.26 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=COCO-么么哒, createdTime=Sun Aug 07 13:58:40 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158571, encodeId=e37e21585e140, content=偏重的研究方向：发育 经验分享：投稿的友友们， 我是9.17 投稿 9.18 分配编辑 9.19 Under review 我想问一下Under review 不属于外审，是期刊内部评审，意思是主编那关已经过了吗？送外审的可能性大嘛有知道的友友可以麻烦回复告知指点一下嘛~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77c6565435, createdName=ms8000000172957012, createdTime=Tue Sep 19 20:55:28 CST 2023, time=2023-09-19, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2201363, encodeId=ae672201363d5, content=请问一下，这个期刊什么时候送外审？会有状态变化或者邮件告知吗？投稿已经两周了，一直是Under Review状态，旁边显示“This submission is under consideration and cannot be edited. Further information will be emailed to you by the journal editorial office.”, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8332469177, createdName=12433741m11(暂无昵称), createdTime=Wed May 01 11:16:29 CST 2024, time=2024-05-01, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2204994, encodeId=1c162204994e2, content=请问是小CDD口碑好，还是CELL PROLIFERATION口碑好哇？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8332469177, createdName=12433741m11(暂无昵称), createdTime=Thu May 16 11:05:39 CST 2024, time=2024-05-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2153391, encodeId=54492153391da, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：第二次显示awaiting editor decision一周多了……第一次的时候三天又变成等待评分……这次一周也没变化了……有知道的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200608/69dd05c9fcfa4768838a5589b5b25dd6/e3def69d3a5a45e8b6b33e44bf34132b.jpg, createdBy=8b9295286, createdName=刘洋1981, createdTime=Fri Aug 18 11:32:32 CST 2023, time=2023-08-18, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=977961, encodeId=49329e7961a0, content=偏重的研究方向：增殖;肿瘤 经验分享：投稿后拒稿快吗？不会等了一个月又被拒吧😭伤不起了我<a href='/topic/show?id=2daf446643' target=_blank style='color:#2F92EE;'>#cell proliferation#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=4466, encryptionId=2daf446643, topicName=cell proliferation)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/9883684c50eb4525aa0007900c15ab09/c44d99673a04497daa77b8386586df68.jpg, createdBy=70f62430863, createdName=lovebanana, createdTime=Tue Jun 29 16:44:46 CST 2021, time=2021-06-29, status=1, ipAttribution=)]

2023-09-19 ms8000000172957012 来自香港

偏重的研究方向：发育
经验分享：投稿的友友们，
我是9.17 投稿
9.18 分配编辑
9.19 Under review
我想问一下Under review 不属于外审，是期刊内部评审，意思是主编那关已经过了吗？送外审的可能性大嘛有知道的友友可以麻烦回复告知指点一下嘛~

49 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=2203621, encodeId=60a722036217f, content=旧的系统显示了Under review，是送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小王, createdTime=Thu May 09 10:29:11 CST 2024, time=2024-05-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2118154, encodeId=430721181541e, content=2月15号投稿，现在3月7号，还在awaiting reviewer assignment，发邮件没回应，托人问了华西的副主编，说帮忙看下，3天了也没动静，正在考虑转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61698567057, createdName=ms5000001252099123, createdTime=Tue Mar 07 17:36:16 CST 2023, time=2023-03-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2145106, encodeId=955021451062a, content=偏重的研究方向：肿瘤基础研究;干细胞;肿瘤生物学 经验分享：外审5个月，4个小修，编辑拒稿。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5a28115392, createdName=ms3000000199710851, createdTime=Tue Jun 27 22:54:13 CST 2023, time=2023-06-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2097725, encodeId=4d75209e7251f, content=偏重的研究方向：细胞增殖 经验分享：分值高的二区杂志，6个审稿人给了一些不痛不痒的小意见，没有拒稿，但是被编辑给拒了，垃圾。转投了其他一区杂志，接受了，因祸得福, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb028255336, createdName=ms6000000988225388, createdTime=Tue Nov 01 03:34:30 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237083, encodeId=4a0b123e083bd, content=2.25 投稿，不知为何，5月才开始外审， 6.3通知Major revision，6.20修回，7.14通知Minor revision，7.26 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=COCO-么么哒, createdTime=Sun Aug 07 13:58:40 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158571, encodeId=e37e21585e140, content=偏重的研究方向：发育 经验分享：投稿的友友们， 我是9.17 投稿 9.18 分配编辑 9.19 Under review 我想问一下Under review 不属于外审，是期刊内部评审，意思是主编那关已经过了吗？送外审的可能性大嘛有知道的友友可以麻烦回复告知指点一下嘛~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77c6565435, createdName=ms8000000172957012, createdTime=Tue Sep 19 20:55:28 CST 2023, time=2023-09-19, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2201363, encodeId=ae672201363d5, content=请问一下，这个期刊什么时候送外审？会有状态变化或者邮件告知吗？投稿已经两周了，一直是Under Review状态，旁边显示“This submission is under consideration and cannot be edited. Further information will be emailed to you by the journal editorial office.”, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8332469177, createdName=12433741m11(暂无昵称), createdTime=Wed May 01 11:16:29 CST 2024, time=2024-05-01, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2204994, encodeId=1c162204994e2, content=请问是小CDD口碑好，还是CELL PROLIFERATION口碑好哇？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8332469177, createdName=12433741m11(暂无昵称), createdTime=Thu May 16 11:05:39 CST 2024, time=2024-05-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2153391, encodeId=54492153391da, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：第二次显示awaiting editor decision一周多了……第一次的时候三天又变成等待评分……这次一周也没变化了……有知道的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200608/69dd05c9fcfa4768838a5589b5b25dd6/e3def69d3a5a45e8b6b33e44bf34132b.jpg, createdBy=8b9295286, createdName=刘洋1981, createdTime=Fri Aug 18 11:32:32 CST 2023, time=2023-08-18, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=977961, encodeId=49329e7961a0, content=偏重的研究方向：增殖;肿瘤 经验分享：投稿后拒稿快吗？不会等了一个月又被拒吧😭伤不起了我<a href='/topic/show?id=2daf446643' target=_blank style='color:#2F92EE;'>#cell proliferation#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=4466, encryptionId=2daf446643, topicName=cell proliferation)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/9883684c50eb4525aa0007900c15ab09/c44d99673a04497daa77b8386586df68.jpg, createdBy=70f62430863, createdName=lovebanana, createdTime=Tue Jun 29 16:44:46 CST 2021, time=2021-06-29, status=1, ipAttribution=)]

2024-05-01 12433741m11(暂无昵称) 来自湖北省

请问一下，这个期刊什么时候送外审？会有状态变化或者邮件告知吗？投稿已经两周了，一直是Under Review状态，旁边显示“This submission is under consideration and cannot be edited. Further information will be emailed to you by the journal editorial office.”

10 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2203621, encodeId=60a722036217f, content=旧的系统显示了Under review，是送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小王, createdTime=Thu May 09 10:29:11 CST 2024, time=2024-05-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2118154, encodeId=430721181541e, content=2月15号投稿，现在3月7号，还在awaiting reviewer assignment，发邮件没回应，托人问了华西的副主编，说帮忙看下，3天了也没动静，正在考虑转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61698567057, createdName=ms5000001252099123, createdTime=Tue Mar 07 17:36:16 CST 2023, time=2023-03-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2145106, encodeId=955021451062a, content=偏重的研究方向：肿瘤基础研究;干细胞;肿瘤生物学 经验分享：外审5个月，4个小修，编辑拒稿。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5a28115392, createdName=ms3000000199710851, createdTime=Tue Jun 27 22:54:13 CST 2023, time=2023-06-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2097725, encodeId=4d75209e7251f, content=偏重的研究方向：细胞增殖 经验分享：分值高的二区杂志，6个审稿人给了一些不痛不痒的小意见，没有拒稿，但是被编辑给拒了，垃圾。转投了其他一区杂志，接受了，因祸得福, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb028255336, createdName=ms6000000988225388, createdTime=Tue Nov 01 03:34:30 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237083, encodeId=4a0b123e083bd, content=2.25 投稿，不知为何，5月才开始外审， 6.3通知Major revision，6.20修回，7.14通知Minor revision，7.26 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=COCO-么么哒, createdTime=Sun Aug 07 13:58:40 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158571, encodeId=e37e21585e140, content=偏重的研究方向：发育 经验分享：投稿的友友们， 我是9.17 投稿 9.18 分配编辑 9.19 Under review 我想问一下Under review 不属于外审，是期刊内部评审，意思是主编那关已经过了吗？送外审的可能性大嘛有知道的友友可以麻烦回复告知指点一下嘛~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77c6565435, createdName=ms8000000172957012, createdTime=Tue Sep 19 20:55:28 CST 2023, time=2023-09-19, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2201363, encodeId=ae672201363d5, content=请问一下，这个期刊什么时候送外审？会有状态变化或者邮件告知吗？投稿已经两周了，一直是Under Review状态，旁边显示“This submission is under consideration and cannot be edited. Further information will be emailed to you by the journal editorial office.”, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8332469177, createdName=12433741m11(暂无昵称), createdTime=Wed May 01 11:16:29 CST 2024, time=2024-05-01, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2204994, encodeId=1c162204994e2, content=请问是小CDD口碑好，还是CELL PROLIFERATION口碑好哇？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8332469177, createdName=12433741m11(暂无昵称), createdTime=Thu May 16 11:05:39 CST 2024, time=2024-05-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2153391, encodeId=54492153391da, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：第二次显示awaiting editor decision一周多了……第一次的时候三天又变成等待评分……这次一周也没变化了……有知道的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200608/69dd05c9fcfa4768838a5589b5b25dd6/e3def69d3a5a45e8b6b33e44bf34132b.jpg, createdBy=8b9295286, createdName=刘洋1981, createdTime=Fri Aug 18 11:32:32 CST 2023, time=2023-08-18, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=977961, encodeId=49329e7961a0, content=偏重的研究方向：增殖;肿瘤 经验分享：投稿后拒稿快吗？不会等了一个月又被拒吧😭伤不起了我<a href='/topic/show?id=2daf446643' target=_blank style='color:#2F92EE;'>#cell proliferation#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=4466, encryptionId=2daf446643, topicName=cell proliferation)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/9883684c50eb4525aa0007900c15ab09/c44d99673a04497daa77b8386586df68.jpg, createdBy=70f62430863, createdName=lovebanana, createdTime=Tue Jun 29 16:44:46 CST 2021, time=2021-06-29, status=1, ipAttribution=)]

2024-05-16 12433741m11(暂无昵称) 来自湖北省

请问是小CDD口碑好，还是CELL PROLIFERATION口碑好哇？

7 0

[GetPortalCommentsPageByObjectIdResponse(id=2203621, encodeId=60a722036217f, content=旧的系统显示了Under review，是送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小王, createdTime=Thu May 09 10:29:11 CST 2024, time=2024-05-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2118154, encodeId=430721181541e, content=2月15号投稿，现在3月7号，还在awaiting reviewer assignment，发邮件没回应，托人问了华西的副主编，说帮忙看下，3天了也没动静，正在考虑转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61698567057, createdName=ms5000001252099123, createdTime=Tue Mar 07 17:36:16 CST 2023, time=2023-03-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2145106, encodeId=955021451062a, content=偏重的研究方向：肿瘤基础研究;干细胞;肿瘤生物学 经验分享：外审5个月，4个小修，编辑拒稿。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5a28115392, createdName=ms3000000199710851, createdTime=Tue Jun 27 22:54:13 CST 2023, time=2023-06-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2097725, encodeId=4d75209e7251f, content=偏重的研究方向：细胞增殖 经验分享：分值高的二区杂志，6个审稿人给了一些不痛不痒的小意见，没有拒稿，但是被编辑给拒了，垃圾。转投了其他一区杂志，接受了，因祸得福, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb028255336, createdName=ms6000000988225388, createdTime=Tue Nov 01 03:34:30 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237083, encodeId=4a0b123e083bd, content=2.25 投稿，不知为何，5月才开始外审， 6.3通知Major revision，6.20修回，7.14通知Minor revision，7.26 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=COCO-么么哒, createdTime=Sun Aug 07 13:58:40 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158571, encodeId=e37e21585e140, content=偏重的研究方向：发育 经验分享：投稿的友友们， 我是9.17 投稿 9.18 分配编辑 9.19 Under review 我想问一下Under review 不属于外审，是期刊内部评审，意思是主编那关已经过了吗？送外审的可能性大嘛有知道的友友可以麻烦回复告知指点一下嘛~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77c6565435, createdName=ms8000000172957012, createdTime=Tue Sep 19 20:55:28 CST 2023, time=2023-09-19, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2201363, encodeId=ae672201363d5, content=请问一下，这个期刊什么时候送外审？会有状态变化或者邮件告知吗？投稿已经两周了，一直是Under Review状态，旁边显示“This submission is under consideration and cannot be edited. Further information will be emailed to you by the journal editorial office.”, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8332469177, createdName=12433741m11(暂无昵称), createdTime=Wed May 01 11:16:29 CST 2024, time=2024-05-01, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2204994, encodeId=1c162204994e2, content=请问是小CDD口碑好，还是CELL PROLIFERATION口碑好哇？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8332469177, createdName=12433741m11(暂无昵称), createdTime=Thu May 16 11:05:39 CST 2024, time=2024-05-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2153391, encodeId=54492153391da, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：第二次显示awaiting editor decision一周多了……第一次的时候三天又变成等待评分……这次一周也没变化了……有知道的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200608/69dd05c9fcfa4768838a5589b5b25dd6/e3def69d3a5a45e8b6b33e44bf34132b.jpg, createdBy=8b9295286, createdName=刘洋1981, createdTime=Fri Aug 18 11:32:32 CST 2023, time=2023-08-18, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=977961, encodeId=49329e7961a0, content=偏重的研究方向：增殖;肿瘤 经验分享：投稿后拒稿快吗？不会等了一个月又被拒吧😭伤不起了我<a href='/topic/show?id=2daf446643' target=_blank style='color:#2F92EE;'>#cell proliferation#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=4466, encryptionId=2daf446643, topicName=cell proliferation)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/9883684c50eb4525aa0007900c15ab09/c44d99673a04497daa77b8386586df68.jpg, createdBy=70f62430863, createdName=lovebanana, createdTime=Tue Jun 29 16:44:46 CST 2021, time=2021-06-29, status=1, ipAttribution=)]

2023-08-18 刘洋1981 来自浙江省

审稿速度:2.0 | 投稿命中率:50.0
经验分享：第二次显示awaiting editor decision一周多了……第一次的时候三天又变成等待评分……这次一周也没变化了……有知道的嘛

60 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2203621, encodeId=60a722036217f, content=旧的系统显示了Under review，是送外审了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小王, createdTime=Thu May 09 10:29:11 CST 2024, time=2024-05-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2118154, encodeId=430721181541e, content=2月15号投稿，现在3月7号，还在awaiting reviewer assignment，发邮件没回应，托人问了华西的副主编，说帮忙看下，3天了也没动静，正在考虑转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61698567057, createdName=ms5000001252099123, createdTime=Tue Mar 07 17:36:16 CST 2023, time=2023-03-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2145106, encodeId=955021451062a, content=偏重的研究方向：肿瘤基础研究;干细胞;肿瘤生物学 经验分享：外审5个月，4个小修，编辑拒稿。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5a28115392, createdName=ms3000000199710851, createdTime=Tue Jun 27 22:54:13 CST 2023, time=2023-06-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2097725, encodeId=4d75209e7251f, content=偏重的研究方向：细胞增殖 经验分享：分值高的二区杂志，6个审稿人给了一些不痛不痒的小意见，没有拒稿，但是被编辑给拒了，垃圾。转投了其他一区杂志，接受了，因祸得福, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb028255336, createdName=ms6000000988225388, createdTime=Tue Nov 01 03:34:30 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237083, encodeId=4a0b123e083bd, content=2.25 投稿，不知为何，5月才开始外审， 6.3通知Major revision，6.20修回，7.14通知Minor revision，7.26 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=COCO-么么哒, createdTime=Sun Aug 07 13:58:40 CST 2022, time=2022-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158571, encodeId=e37e21585e140, content=偏重的研究方向：发育 经验分享：投稿的友友们， 我是9.17 投稿 9.18 分配编辑 9.19 Under review 我想问一下Under review 不属于外审，是期刊内部评审，意思是主编那关已经过了吗？送外审的可能性大嘛有知道的友友可以麻烦回复告知指点一下嘛~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77c6565435, createdName=ms8000000172957012, createdTime=Tue Sep 19 20:55:28 CST 2023, time=2023-09-19, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2201363, encodeId=ae672201363d5, content=请问一下，这个期刊什么时候送外审？会有状态变化或者邮件告知吗？投稿已经两周了，一直是Under Review状态，旁边显示“This submission is under consideration and cannot be edited. Further information will be emailed to you by the journal editorial office.”, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8332469177, createdName=12433741m11(暂无昵称), createdTime=Wed May 01 11:16:29 CST 2024, time=2024-05-01, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2204994, encodeId=1c162204994e2, content=请问是小CDD口碑好，还是CELL PROLIFERATION口碑好哇？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8332469177, createdName=12433741m11(暂无昵称), createdTime=Thu May 16 11:05:39 CST 2024, time=2024-05-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2153391, encodeId=54492153391da, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：第二次显示awaiting editor decision一周多了……第一次的时候三天又变成等待评分……这次一周也没变化了……有知道的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200608/69dd05c9fcfa4768838a5589b5b25dd6/e3def69d3a5a45e8b6b33e44bf34132b.jpg, createdBy=8b9295286, createdName=刘洋1981, createdTime=Fri Aug 18 11:32:32 CST 2023, time=2023-08-18, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=977961, encodeId=49329e7961a0, content=偏重的研究方向：增殖;肿瘤 经验分享：投稿后拒稿快吗？不会等了一个月又被拒吧😭伤不起了我<a href='/topic/show?id=2daf446643' target=_blank style='color:#2F92EE;'>#cell proliferation#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=4466, encryptionId=2daf446643, topicName=cell proliferation)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/9883684c50eb4525aa0007900c15ab09/c44d99673a04497daa77b8386586df68.jpg, createdBy=70f62430863, createdName=lovebanana, createdTime=Tue Jun 29 16:44:46 CST 2021, time=2021-06-29, status=1, ipAttribution=)]

2021-06-29 lovebanana

偏重的研究方向：增殖;肿瘤
经验分享：投稿后拒稿快吗？不会等了一个月又被拒吧😭伤不起了我#cell proliferation#

50 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务